BLAST CELL COUNT INCREASED side effect
What is BLAST CELL COUNT INCREASED ?Drugs associated with BLAST CELL COUNT INCREASED
CLOFARABINE CYCLOSPORINE DASATINIB GLEEVEC MYLOTARG NEORAL NOVANTRONE STEMGENBLAST CELL COUNT INCREASED : Dasatinib Side Effects Report #5657195-1
Consumer or non-health professional from SWEDEN reported DASATINIB problem on Mar 05, 2008. Male patient, 59 years of age, was diagnosed with chronic myeloid leukaemia and was treated with DASATINIB. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, dyspnoea, pleural effusion, . DASATINIB dosage: 140MG 08JUN TO 08JUL-05; 200MG 08JUL05 TO 17JAN06, 27JAN TO 15FEB06; 140MG 18FEB TO 28FEB06. During the same period patient was treated with DARBEPOETIN ALFA, TRAMADOL, CYANOCOBALAMIN, ALLOPURINOL, ACETAMINOPHEN, LOPERAMIDE, FLUCONAZOLE, FUROSEMIDE. Patient was hospitalized. Patient died.
BLAST CELL COUNT INCREASED : Dasatinib Side Effects Report #5661837-4
DASATINIB problem was reported by a Consumer or non-health professional from SWEDEN on Mar 05, 2008. Male patient, 59 years of age, was diagnosed with chronic myeloid leukaemia and was treated with DASATINIB. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, dyspnoea, malignant neoplasm progression, pleural effusion, . DASATINIB dosage: 140MG 08JUN TO 08JUL-05; 200MG 08JUL05 TO 17JAN06, 27JAN TO 15FEB06; 140MG 18FEB TO 28FEB06. During the same period patient was treated with DARBEPOETIN ALFA, TRAMADOL, CYANOCOBALAMIN, ALLOPURINOL, ACETAMINOPHEN, LOPERAMIDE, FLUCONAZOLE, FUROSEMIDE. Patient was hospitalized. Patient died on 05/26/2006.
BLAST CELL COUNT INCREASED : Cyclosporine Side Effects Report #5680201-5
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Mar 19, 2008. Female patient, child 10 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, graft versus host disease, graft versus host disease in lung, obliterative bronchiolitis, . CYCLOSPORINE dosage: 1MG/KG/DAY. During the same period patient was treated with METHOTREXATE, TACROLIMUS, PREDNISOLONE. Patient died.
BLAST CELL COUNT INCREASED : Stemgen Side Effects Report #5682417-0
STEMGEN problem was reported by a Physician from FRANCE on Mar 12, 2008. Male patient, weighting 168.7 lb, was diagnosed with peripheral blood stem cell apheresis, blood stem cell harvest and was treated with STEMGEN. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, . STEMGEN dosage: unknown. During the same period patient was treated with NEUPOGEN, VENTOLIN, ZYRTEC, RANITIDINE, VALACYCLOVIR, PENTACARINAT, ARACYTINE. Patient was hospitalized. Patient recovered.
BLAST CELL COUNT INCREASED : Gleevec Side Effects Report #5474457-1
Physician from CANADA reported GLEEVEC problem on Sept 25, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, pulmonary mass, . GLEEVEC dosage: 600 MG, QD. Patient was hospitalized. Patient recovered.
BLAST CELL COUNT INCREASED : Novantrone Side Effects Report #5420196-2
NOVANTRONE problem was reported by a Consumer or non-health professional from FRANCE on Aug 06, 2007. Male patient, 17 years of age, was diagnosed with acute myeloid leukaemia, bronchopulmonary aspergillosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, bronchopulmonary aspergillosis, cardio-respiratory arrest, cerebellar syndrome, coma, confusional state, convulsion, decerebration, eye movement disorder, . NOVANTRONE dosage: 20 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, AMIKLIN, AMISIDINE, CYTARABINE. Patient was hospitalized. Patient died on 06/10/2007.
BLAST CELL COUNT INCREASED : Neoral Side Effects Report #5662694-2
Consumer or non-health professional from JAPAN reported NEORAL problem on Mar 05, 2008. Male patient, 55 years of age, was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, blast cell count increased, cholecystitis infective, cytogenetic abnormality, cytomegalovirus enterocolitis, engraftment syndrome, herpes zoster, leukaemia, marrow hyperplasia, . NEORAL dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE, FLUDARABINE, CYCLOPHOSPHAMIDE, IRRADIATION. Patient was hospitalized. Patient died.
BLAST CELL COUNT INCREASED : Gleevec Side Effects Report #5573294-7
GLEEVEC problem was reported by a Physician from JAPAN on Dec 21, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, blood creatinine increased, bone pain, brain oedema, dyslalia, eosinophil count increased, haematocrit decreased, haemoglobin decreased, . GLEEVEC dosage: 100 MG, QD. Patient was hospitalized and became disabled. Patient died on 09/21/2005.
BLAST CELL COUNT INCREASED : Gleevec Side Effects Report #5575997-7
Physician from CANADA reported GLEEVEC problem on Dec 21, 2007. Male patient, 68 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, myelocyte count increased, platelet count decreased, . GLEEVEC dosage: 600 MG, QD. Patient was hospitalized. Patient recovered.
BLAST CELL COUNT INCREASED : Gleevec Side Effects Report #5501780-4
GLEEVEC problem was reported by a Physician from JAPAN on Oct 26, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, blood creatinine increased, bone pain, brain oedema, dyslalia, eosinophil count increased, haematocrit decreased, haemoglobin decreased, . GLEEVEC dosage: 100 MG, QD. Patient was hospitalized and became disabled. Patient died on 09/21/2005.
BLAST CELL COUNT INCREASED : Gleevec Side Effects Report #5502556-4
Physician from JAPAN reported GLEEVEC problem on Oct 26, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: basophil count increased, blast cell count increased, blood creatinine increased, bone pain, brain oedema, dyslalia, eosinophil count increased, haematocrit decreased, haemoglobin decreased, . GLEEVEC dosage: 100 MG, QD. Patient was hospitalized and became disabled. Patient died on 09/21/2005.
BLAST CELL COUNT INCREASED : Clofarabine Side Effects Report #5407908-9
CLOFARABINE problem was reported by a Physician from UNITED STATES on Apr 24, 2007. Male patient, 17 years of age, weighting 88.18 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, blast cell count increased, blast cells present, blood culture positive, blood glucose increased, blood phosphorus decreased, blood pressure decreased, bone marrow failure, caecitis, . CLOFARABINE dosage: 42 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, BACTRIM, POTASSIUM CHLORIDE, VALTREX, COLACE, MYLANTA, OXYCONTIN. Patient was hospitalized. Patient recovered.
BLAST CELL COUNT INCREASED : Mylotarg Side Effects Report #5404331-8
Physician from JAPAN reported MYLOTARG problem on July 26, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, blast cell count increased, blood potassium increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, . MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, DIFLUCAN, POLYMYXIN B SULPHATE, ZANTAC, MUCOSTA. Patient was hospitalized. Patient recovered.